Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2204 of 6351
-
New drug FXB0871 takes on advanced cancers in first human trial
Disease control Not yet recruitingThis is a phase 1a/1b, open-label, multicenter, dose-escalation and dose-expansion study evaluating the safety, tolerability, antitumor activity, pharmacokinetics, and pharmacodynamics of FXB0871 monotherapy in adults with selected locally advanced or metastatic solid tumors. In …
Phase 1 • Sponsor: Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Exercise after cancer surgery: a new prescription for recovery?
Disease control Recruiting nowThis randomized controlled trial aims to determine the optimal exercise intensity for improving postoperative recovery in patients with upper gastrointestinal cancer. Participants who have undergone curative surgery will be randomly assigned to high-intensity interval training (H…
Sponsor: Kansai Medical University • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New study seeks to improve quality of life for advanced breast cancer patients
Symptom relief Recruiting nowA real-world, multicenter, prospective study to evaluate the patient-reported outcome in Chinese patients who received sacituzumab govitecan or chemotherapy of the physician's choice for metastatic breast cancer progressing on first-line treatment
Sponsor: Fudan University • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Ultrasound-Guided nerve block may ease a hidden cause of chronic back pain
Symptom relief Recruiting nowSuperior cluneal nerve entrapment (SCNE) is an underrecognized cause of chronic low back pain and gluteal pain that may mimic lumbar spine disorders. Ultrasound-guided proximal superior cluneal nerve block has increasingly been used in routine clinical practice .Diagnostic superi…
Sponsor: Gaziosmanpasa Research and Education Hospital • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC
-
AI could help predict basketball injuries before they happen
Knowledge-focused CompletedThis observational study aims to evaluate lower extremity performance characteristics in young male basketball players according to their playing positions and to explore injury risk patterns using artificial intelligence (AI)-based analysis. Basketball requires frequent jumping,…
Sponsor: Istanbul Gelisim University • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Natural supplement astaxanthin tested as new asthma aid in dirty air
Disease control Recruiting nowThis study will test whether astaxanthin, a naturally occurring antioxidant supplement, can improve lung function, reduce airway inflammation, and improve asthma control in adults with mild-to-moderate asthma. Participants will receive astaxanthin and placebo in random order in a…
Sponsor: Middlesex University • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Blood marker may uncover fracture risk hidden from bone scans
Knowledge-focused Recruiting nowOsteoporosis is a major cause of morbidity and fragility fractures in postmenopausal women. Bone mineral density (BMD) alone may not fully reflect fracture risk and skeletal fragility. Lumican, an extracellular matrix proteoglycan involved in collagen organization and musculoskel…
Sponsor: Kanuni Sultan Suleyman Training and Research Hospital • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
ALS drug safety check: new study tests Long-Term effects
Disease control Recruiting nowStudy OLMP is a master protocol that will support a collection of individual sub studies that share key design components. Participants from the originator study OWAA (NCT07100119) will be assigned to the appropriate study treatment group: Sporadic Amyotrophic Lateral Sclerosis O…
Phase 1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Flavor variety may boost quit rates in smokers switching to E-Cigs
Disease control Recruiting nowThe overall purpose of this study will be to assess primary combustible cigarette users' abstinence from smoking their usual brand of combustible cigarettes at the end of the study, when provided with an electronic nicotine delivery system (ENDS) power unit (2) and varying levels…
Sponsor: RAI Services Company • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New shot aims to tame hepatitis b virus
Disease control Recruiting nowStudy HH006-202 is designed to assesses the efficacy and safety of HH-006 in adults chronic HBV infection. Eligible participants will receive study treatment for 48 weeks. All treated patients will also undergo a follow-up period after last study drug treatment.
Phase 2 • Sponsor: Huahui Health • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a simple text message save lives? new study tests suicide prevention after ER discharge
Symptom relief Recruiting nowThe researchers hope to learn whether an electronic safety plan (ESP) and a supportive text messaging program are feasible and acceptable to adult patients with recent suicidal thoughts or behavior after emergency department (ED) discharge. From this study, the researchers also h…
Sponsor: University of Michigan • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
Can an arthritis drug curb alcohol cravings? new trial aims to find out
Disease control Recruiting nowFor this protocol, the investigators plan to collect data to evaluate apremilast (60mg/day) vs placebo in adults with Alcohol Use Disorders (AUD).
Phase 2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Parkinson's drug repurposed to fight kidney disease?
Disease control Recruiting nowAutosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease and is caused by mutations in the PKD1 or PKD2 genes, which encode polycystins 1 and 2. Patients develop renal cysts associated with a progressive decline in kidney function, ultimat…
Phase 2 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
One-Size-Fits-All oxygen may be outdated: new trial tests personalized targets
Disease control By invitation onlyMechanical ventilation involves titrating the fraction of inspired oxygen to maintain arterial oxygen saturation (SpO2). The SpO2 target that results in the best outcomes for critically ill adults has historically been unknown. Randomized trials comparing use of a higher SpO2 tar…
Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New shot aims to tame dangerous fat levels in blood
Disease control Recruiting nowThe main objective of this study is to evaluate the effect of ION775 on fasting triglyceride (TG) levels in participants with hypertriglyceridemia (HTG) and severe hypertriglyceridemia (sHTG).
Phase 2 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New Dual-Scope surgery shows promise for early stomach cancer
Disease control OngoingThis study is to evaluate the safety and efficacy of dual-endoscope assisted sentinel lymph node navigation surgery for early gastric cancer (EGC).
Sponsor: Jilin University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New cancer drug TAK-505 enters first human trials
Disease control Recruiting nowSolid tumors occur when cells in an organ or tissue (for example in the lung or liver) start growing out of control (cancer) and form a lump or mass of cells. These solid cancers may grow very far in the general area where they started (called locally advanced) or may spread to o…
Phase 1/2 • Sponsor: Takeda • Aim: Disease control
Last updated Sep 09, 2026 23:00 UTC
-
Can four therapy sessions stop suicide reattempts? swedish study aims to find out
Knowledge-focused Recruiting nowThe goal of this study is to determine whether Brief Cognitive Behaviour Therapy (BCBT), a four-session psychological treatment aimed at reducing suicide attempts, is acceptable and feasible to deliver during psychiatric inpatient care for adults who have been hospitalised follow…
Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
Heart drug pelacarsen tested for Long-Term safety in 5,700 patients
Disease control Recruiting nowThis open-label extension study will provide post-trial access to pelacarsen (TQJ230) to participants who have successfully completed the double-blind parent study (CTQJ230A12301).
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
JAKAVI under the microscope: new study tracks GVHD treatment in real life
Disease control Recruiting nowThis study aims to evaluate the safety and effectiveness of Jakavi® (ruxolitinib) in patients with acute graft-versus host disease (GVHD) and chronic GVHD in clinical practice.
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC